EATONTOWN, N.J., April 11, 2012 /PRNewswire/ -- To kick off National Infertility Awareness Week on Sunday, April 22, fertility experts from Reproductive Medicine Associates of New Jersey (RMANJ) will offer a day of free educational presentations aimed at helping nurses from around the region better understand the latest strategies for evaluating and treating infertile couples.
The program, "Innovations in Assisted Reproduction: An Update for the Nursing Professional" is scheduled for 7:00 a.m. to 2:00 p.m. at the Oyster Point Hotel in Red Bank, NJ. Nursing providers, including RN, LPN, NP and CNM, will receive six contact hours upon completion. More information is available at http://www.rmanj.com and nurses can RSVP at email@example.com or 973-656-2089.
Speakers Thomas A. Molinaro, M.D., FACOG; Shefali Mavani Shastri, M.D., FACOG; Marcy F. Maguire, M.D.; and Alana Shear, BSN, RN will update the general OB/GYN nursing professional on the latest evidence-based methods for diagnosing and treating infertility, including:
- Advances in assisted reproductive technology (ART) that are making infertility treatment more successful with fewer multiple pregnancies;
- Ways that non-traditional patients might benefit from an evaluation and treatment with a reproductive endocrinologist.
"At RMANJ we are committed to addressing the educational needs of providers with an interest in reproductive endocrinology, genetic testing and assisted reproductive technologies," said Thomas A. Molinaro, M.D., from RMANJ's Eatontown office.
RMANJ has one of the highest in vitro fertilization (IVF) success rates in the country, and last month published research showing that its optimized method of Comprehensive Chromosome Screening (CCS) is the first technology capable of accurate aneuploidy screening (abnormal number of chromosomes) of all 24 chromosomes in four hours. This allows for same-day screening for chromosomal abnormalities with subsequent fresh embryo transfer in IVF.
The findings appeared in the April 2012 issue of Fertility & Sterility (Volume 97, Issue 4) and were designated a "Seminal Contribution" due to their broad-reaching implications to increase implantation rates, dramatically reduce miscarriage rates, and also reduce the need to transfer multiple embryos to achieve conception.
"We are proud of our contributions to fertility medicine, and we're dedicated to the ultimate reproductive medicine goal of 'one embryo, one healthy baby,'" said Richard T. Scott, M.D. and founding partner, RMANJ. "Sharing fertility best practices with medical professionals around our region plays a significant role in that mission."
About Reproductive Medicine Associates of New Jersey
Reproductive Medicine Associates of New Jersey have pioneered and successfully implemented a cutting-edge technology, known as Comprehensive Chromosome Screening (CCS) to more accurately detect healthy embryos that will lead to successful pregnancies and ultimately healthy babies. Other centers have attempted similar testing methods, but RMANJ is the only fertility center in the world to have developed a system of unprecedented accuracy, fully validated through years of rigorous clinical research. RMANJ's Comprehensive Chromosome Screening offers advanced embryo selection with extreme accuracy by detecting and avoiding use of embryos with chromosomal abnormalities prior to transfer and pregnancy.
The fertility experts at RMANJ have among the highest IVF success rates in the country. Since 1999, they have helped bring more than 20,000 babies to loving families. In addition to serving as the Division of Reproductive Endocrinology at Robert Wood Johnson University Medical School in New Brunswick, NJ, the practice has six locations in New Jersey. For more information please call RMANJ at 973-656-2089, or visit www.rmanj.com.
SOURCE Reproductive Medicine Associates of New Jersey